98 related articles for article (PubMed ID: 28494520)
1. Characterization of TP53 mutations in clonal cytopenia of undetermined significance.
Wang W; Routbort MJ; Ok CY; Patel KP; Sun Y; Kanagal-Shamanna R; Medeiros LJ; Wang SA
Am J Hematol; 2017 Aug; 92(8):E175-E177. PubMed ID: 28494520
[No Abstract] [Full Text] [Related]
2. Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes.
Hansen JW; Westman MK; Sjö LD; Saft L; Kristensen LS; Ørskov AD; Treppendahl M; Andersen MK; Grønbaek K
Am J Hematol; 2016 Dec; 91(12):1234-1238. PubMed ID: 27717004
[TBL] [Abstract][Full Text] [Related]
3. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
Mod Pathol; 2016 Sep; 29(9):996-1003. PubMed ID: 27255165
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome.
Pavlu J; Emmerson J; Marks AJ; Bain BJ
Leuk Lymphoma; 2011 Mar; 52(3):515-6. PubMed ID: 21323527
[TBL] [Abstract][Full Text] [Related]
5. [The cause of cytopenia of undetermined significance can often be found by using next generation sequencing].
Hansen JW; Husby S; Grønbæk K
Ugeskr Laeger; 2017 Jun; 179(25):. PubMed ID: 28648154
[TBL] [Abstract][Full Text] [Related]
6. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
[TBL] [Abstract][Full Text] [Related]
7. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
Malcovati L; Cazzola M
Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.
Schroeder T; Ruf L; Bernhardt A; Hildebrandt B; Aivado M; Aul C; Gattermann N; Haas R; Germing U
Ann Oncol; 2010 Nov; 21(11):2267-2271. PubMed ID: 20439346
[TBL] [Abstract][Full Text] [Related]
9. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
Misawa S; Horiike S; Kaneko H; Kashima K
Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Wimazal F; Fonatsch C; Thalhammer R; Schwarzinger I; Müllauer L; Sperr WR; Bennett JM; Valent P
Leuk Res; 2007 Nov; 31(11):1461-8. PubMed ID: 17507091
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathologic challenges of clonal cytopenia of undetermined significance.
Weinberg OK
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():82-85. PubMed ID: 34288451
[TBL] [Abstract][Full Text] [Related]
13. ICUS/CCUS/CHIP: basics & beyond.
Jain M; Tripathi A
Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
[TBL] [Abstract][Full Text] [Related]
14. [A 57-year-old patient with peripheral pancytopenia].
Fink M; Prenninger S; Sauer H
Internist (Berl); 1989 Mar; 30(3):210-3. PubMed ID: 2654063
[No Abstract] [Full Text] [Related]
15. Primary autoimmune myelofibrosis as etiology of pancytopenia mimicking myelodysplastic syndrome.
Tang VK; Huh YO; Tayar JH; Rojas Hernandez CM
Leuk Lymphoma; 2016; 57(3):731-4. PubMed ID: 26422082
[No Abstract] [Full Text] [Related]
16. Mutations in the p53 gene in myelodysplastic syndromes.
Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
[TBL] [Abstract][Full Text] [Related]
17. A case with pancytopenia: the role of cytomorphology.
Sukrisman L; Mulansari NA; Sudoyo AW
Acta Med Indones; 2013 Jan; 45(1):67-8. PubMed ID: 23585412
[No Abstract] [Full Text] [Related]
18. [24-year-old male with fever, pancytopenia, and alterations in his state of consciousness].
Saucedo J; Reyes Devesa S
Rev Invest Clin; 1992; 44(2):259-60; discussion 260-7. PubMed ID: 1439316
[No Abstract] [Full Text] [Related]
19. [A Case of Severe, Idiopathic Cytopenia of Undetermined Significance(ICUS)in an Elderly Patient].
Shinohara K
Gan To Kagaku Ryoho; 2016 Jul; 43(7):921-4. PubMed ID: 27431643
[TBL] [Abstract][Full Text] [Related]
20. Hypoplastic myelodysplastic syndrome associated with der(1;7)(q10;p10) presenting as bone marrow failure.
Cho SY; Oh SH; Suh JT; Lee HJ; Lee WI; Baek SK; Cho KS; Park TS
Acta Haematol; 2011; 126(2):110-3. PubMed ID: 21646778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
